InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Lefenfeld Michael, Director. Officer active across 1 companies, notably Immunome Inc.. In total, 2 filings have been logged. Total volume traded: €17k. The latest transaction was disclosed on 24 May 2021 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
€8,744600 shares@ €14.5727100.0% of flow
Common Stock
SEC:0001104659-21-072621·
Ideal exit: 18 Feb 2022 (T+270)
€8,744600 shares@ €14.57270.0004% mcap50.0% of flow
Common Stock
SEC:0001104659-21-072621:0·
Ideal exit: 18 Feb 2022 (T+270)
2 of 2 declarations
About Lefenfeld Michael
Michael Lefenfeld is a Board Member at Immunome Inc. He contributes to the governance of the company, bringing his expertise in the biotechnology field. His role is essential in guiding Immunome in its research and development projects, as well as in its business strategy.
